Literature DB >> 1584807

Quantitation of reversible binding by particle counting: hapten-antibody interaction as a model system.

Y K Sykulev1, D A Sherman, R J Cohen, H N Eisen.   

Abstract

With a view toward developing a general method for measuring intrinsic equilibrium constants for the reversible interactions between two ligands, we used an antibody-hapten model system [2,4-dinitrophenyl (DNP) hapten and anti-DNP antibody] to explore an approach based on particle counting of uniform polystyrene spheres to which the hapten is coupled covalently. This approach was made possible by an optical pulse particle size analyzer that accurately counts individual sphere clusters and quantitates with high precision specific aggregation of spheres crosslinked by antibody. The reduction in crosslinking that results from competition for antibody binding sites between a soluble DNP ligand and immobilized DNP groups on the spheres provides the basis for measuring the intrinsic equilibrium constant for the soluble ligand-antibody interaction. The binding constants measured in this way for several DNP ligands and an anti-DNP antibody (2A1) agreed with the values obtained by conventional methods. The range of intrinsic equilibrium constants that can be determined by particle counting is likely to be exceptionally wide and a value as low as 10(3) liters/mol has been measured. And since all soluble antigens, regardless of their mass, acquire the same ability to scatter light as a result of their immobilization on the much larger uniform spheres (0.36 microns), the approach described here should be applicable to virtually any molecularly dispersed antigen and its monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584807      PMCID: PMC49151          DOI: 10.1073/pnas.89.10.4703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

Review 2.  Dynamic aspects of antibody structure.

Authors:  V N Schumaker; M L Phillips; D C Hanson
Journal:  Mol Immunol       Date:  1991-12       Impact factor: 4.407

Review 3.  Autoantibodies and autoantigens: a conserved system that may shape a primary immunoglobulin gene pool.

Authors:  B D Stollar
Journal:  Mol Immunol       Date:  1991-12       Impact factor: 4.407

4.  Antibody affinity. 3. The role of multivalance.

Authors:  C L Hornick; F Karuch
Journal:  Immunochemistry       Date:  1972-03

5.  The shape of immunoglobulin G molecules in solution.

Authors:  T C Werner; J R Bunting; R E Cathou
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

6.  Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution.

Authors:  R J Poljak; L M Amzel; H P Avey; B L Chen; R P Phizackerley; F Saul
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.

Authors:  F G Cosio; D J Birmingham; D J Sexton; L A Hebert
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

8.  Horizontal saccades induced by stimulation of the central mesencephalic reticular formation.

Authors:  B Cohen; V Matsuo; J Fradin; T Raphan
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

  8 in total
  2 in total

1.  Direct detection of antibody-antigen binding using an on-chip artificial pore.

Authors:  Omar A Saleh; Lydia L Sohn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

2.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

Authors:  E F Ullman; H Kirakossian; S Singh; Z P Wu; B R Irvin; J S Pease; A C Switchenko; J D Irvine; A Dafforn; C N Skold
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.